Alivus Life Sciences Limited (BOM: 543322)

Alivus Life Sciences Statistics

Total Valuation

Alivus Life Sciences has a market cap or net worth of INR 147.07 billion. The enterprise value is 142.77 billion.

Market Cap	147.07B
Enterprise Value	142.77B

Important Dates

The last earnings date was Thursday, January 23, 2025.

Earnings Date	Jan 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.28%
Shares Change (QoQ)	-0.04%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	30.64M

Valuation Ratios

The trailing PE ratio is 33.30.

PE Ratio	33.30
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	5.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	32.32
EV / Sales	6.28
EV / EBITDA	22.89
EV / EBIT	25.15
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	0.03
Debt / FCF	n/a
Interest Coverage	374.02

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	14.30%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	11.29M
Profits Per Employee	2.19M
Employee Count	2,014
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +38.00% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+38.00%
50-Day Moving Average	1,060.07
200-Day Moving Average	990.60
Relative Strength Index (RSI)	66.35
Average Volume (20 Days)	9,094

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Alivus Life Sciences had revenue of INR 22.74 billion and earned 4.42 billion in profits. Earnings per share was 35.93.

Revenue	22.74B
Gross Profit	11.99B
Operating Income	5.68B
Pretax Income	5.93B
Net Income	4.42B
EBITDA	6.21B
EBIT	5.68B
Earnings Per Share (EPS)	35.93

Balance Sheet

The company has 4.46 billion in cash and 159.77 million in debt, giving a net cash position of 4.30 billion.

Cash & Cash Equivalents	4.46B
Total Debt	159.77M
Net Cash	4.30B
Net Cash Per Share	n/a
Equity (Book Value)	25.38B
Book Value Per Share	207.20
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 52.73%, with operating and profit margins of 24.97% and 19.42%.

Gross Margin	52.73%
Operating Margin	24.97%
Pretax Margin	26.06%
Profit Margin	19.42%
EBITDA Margin	27.31%
EBIT Margin	24.97%
FCF Margin	n/a

Dividends & Yields

Alivus Life Sciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-0.28%
Shareholder Yield	-0.28%
Earnings Yield	3.00%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a